A meta-analysis of clinical trials comparing milnacipran, a serotonin--norepinephrine reuptake inhibitor, with a selective serotonin reuptake inhibitor for the treatment of major depressive disorder
about
Milnacipran versus other antidepressive agents for depressionGetting the balance right: Established and emerging therapies for major depressive disordersMilnacipran: a unique antidepressant?Optimizing the Use of Aripiprazole Augmentation in the Treatment of Major Depressive Disorder: From Clinical Trials to Clinical PracticeA systematic review of duloxetine and venlafaxine in major depression, including unpublished data.Treatment goals of depressed outpatients: a qualitative investigation of goals identified by participants in a depression treatment trialDoes adding noradrenaline reuptake inhibition to selective serotonin reuptake inhibition improve efficacy in patients with depression? A systematic review of meta-analyses and large randomised pragmatic trials.The serotonergic system in the neurobiology of depression: Relevance for novel antidepressants.Major Depressive Disorder and Kappa Opioid Receptor Antagonists.Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2000 British Association for Psychopharmacology guidelines.Toward achieving optimal response: understanding and managing antidepressant side effectsEvidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines.Open trial of Vinyasa yoga for persistently depressed individuals: evidence of feasibility and acceptability.Consensus statements on the clinical understanding and use of milnacipran in Hong Kong.Continuing medical education.Depressive Disorders: Major Depressive Disorder and Persistent Depressive Disorder
P2860
Q24240125-1D22F6B4-435B-453F-B602-64BCC38F22C3Q24610225-830D8DA0-D220-4215-AC08-F57195C2B356Q24610271-61B47ED6-5B1A-42E4-876A-D24A860FF9F6Q26797416-040733B7-61AE-4213-8A90-BE8838E50DAFQ33689953-1AD517F4-5061-4BD5-A24A-BB836779C980Q33806404-44D02A68-2144-40E6-BED1-03B2A554D52CQ34355963-F888CF39-595B-4751-B81E-54A90E248CF1Q34497909-20BC7D91-2033-493D-8F8E-357DD7D20ABCQ34527874-13525EA6-48B2-422D-BD25-56016A191497Q34590507-B89B6AF4-D2F4-4291-BC68-15198BD6D310Q35237051-044295A6-2CC9-4CE5-B22E-E322B0699222Q38476909-CAFB2673-B71A-4323-835B-3D98DF63289EQ42657196-E7954C91-DDBD-43E1-AF08-02862100CE67Q47555021-038F4D2B-7A5B-4E88-9DD0-A08DCB5EB427Q51889149-81F3A450-5511-4C04-8FDE-1EDB9759A560Q57703141-59BB23BC-797F-4297-91FA-6347459DDF97
P2860
A meta-analysis of clinical trials comparing milnacipran, a serotonin--norepinephrine reuptake inhibitor, with a selective serotonin reuptake inhibitor for the treatment of major depressive disorder
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
A meta-analysis of clinical tr ...... t of major depressive disorder
@ast
A meta-analysis of clinical tr ...... t of major depressive disorder
@en
A meta-analysis of clinical tr ...... t of major depressive disorder
@nl
type
label
A meta-analysis of clinical tr ...... t of major depressive disorder
@ast
A meta-analysis of clinical tr ...... t of major depressive disorder
@en
A meta-analysis of clinical tr ...... t of major depressive disorder
@nl
prefLabel
A meta-analysis of clinical tr ...... t of major depressive disorder
@ast
A meta-analysis of clinical tr ...... t of major depressive disorder
@en
A meta-analysis of clinical tr ...... t of major depressive disorder
@nl
P1476
A meta-analysis of clinical tr ...... t of major depressive disorder
@en
P2093
George I Papakostas
P356
10.1016/J.EURONEURO.2006.05.001
P407
P577
2007-01-01T00:00:00Z